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Abstract 
Epithelia lining the male reproductive duct modulate fertility by altering the luminal environment 
to which sperm are exposed. Although vas deferens epithelial cells reportedly express high levels 
of cyclooxygenases (Ptgs), and activation of bradykinin (BK) receptors can lead to upregulation 
of PTGS activity in epididymal epithelia, it remains unknown whether BKs and/or PTGSs have 5 
any role in modulating epithelial ion transport across vas deferens epithelia. Porcine and human 
vas deferens epithelial cell primary cultures and the PVD9902 cell line responded to 
lysylbradykinin with an increase in short circuit current (Isc; indicating net anion secretion), an 
effect that was 60-93% reduced by indomethacin. The BK effect was inhibited by the B2 
receptor subtype (BDKRB2) antagonist HOE140, while the B1 receptor subtype agonist des-10 
Arg9-BK had no effect. BDKRB2 immunoreactivity was documented in most epithelial cells 
composing the native epithelium and on Western blots derived from cultured cells. Gene 
expression analysis revealed that the PTGS2 transcript is 20 times more abundant than its PTGS1 
counterpart in cultured porcine vas deferens epithelia and that BDKRB2 mRNA is likewise 
highly expressed. Subsequent experiments revealed that prostaglandin E2, 1-OH prostaglandin 15 
E1 (prostaglandin E receptor 4 [PTGER4] agonist) and butaprost (PTGER2 agonist) increase Isc 
in a concentration-dependent manner, whereas sulprostone (mixed PTGER1 and PTGER3 
agonist) produced no change in Isc. These results demonstrate that autacoids can affect epithelial 
cells to acutely modulate the luminal environment to which sperm are exposed in the vas 
deferens by enhancing PTGS activity leading to the production of prostaglandins that act at 20 
PTGER4 and/or PTGER2 to induce or enhance anion secretion. 
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Introduction 
Autacoids modulate cellular processes, including ion transport across several epithelia, 
and data supporting such functional roles have been accumulating since these compounds were 25 
first described for their potent effect on vascular endothelia [1]. Bradykinin (BK) can be 
synthesized in plasma by plasma kallikrein and its analog lysylbradykinin (LBK) can be 
synthesized on the surface of target cells by tissue kallikrein (tK) [2]. Receptors for bradykinins, 
specifically the B2 receptor subtype (BDKRB2), are present in tracheal and alveolar epithelia [3, 
4] and in renal [5-8], corneal [9] and colonic epithelia [10, 11], where they reportedly stimulate 30 
electrogenic ion transport. In colonic epithelia, BDKRB2-stimulated ion transport is dependent 
on the cystic fibrosis transmembrane conductance regulator (CFTR) [11] channel that conducts 
both chloride and bicarbonate. BDKRB2 transcripts are present in Sertoli cells, epididymal 
epithelia and prostatic epithelial cells of the rat [12, 13], and pharmacological data reveal 
BDKRB2 modulation of cytoplasmic calcium levels in canine prostatic epithelial cells [14]. In 35 
cultured rat epididymal epithelial cells, LBK activates prostaglandin-endoperoxide synthases 
(PTGS [also known as cyclooxygenases 1 and 2]) and increases local prostaglandin (PG) 
synthesis [15, 16]. A primary culture system in which rat epididymal epithelial cells were sorted 
into two populations, basal and principal cells, revealed unique response profiles to LBK. A 
short circuit current (ISC) increase was observed across basal cells but not across principal cells, 40 
unless these were recombined with basal cells. This report indicated that PTGS1 was expressed 
in basal cells but not in principal cells [17]. Of greater interest to the current study are data 
revealing that Ptgs expression is highest in vas deferens epithelia [18]. Semi-quantitative protein 
and gene expression analysis revealed that vas deferens epithelia express both PTGS isoforms at 
the highest levels, when compared to other segments of the mouse reproductive tract. Likewise, 45 
intense PTGS2 immunoreactivity has been demonstrated in epithelial cells lining the human 
distal vas deferens and prostate [19]. To date, it remains unknown whether BKs and/or PTGSs 
have a role in modulating epithelial ion transport across vas deferens epithelia. 
 The goal of this study was to determine whether BKs modulate ion transport across vas 
deferens epithelia. Outcomes demonstrate BK-induced ion transport and suggest that the effects 50 
are mediated by stimulation of PTGS activity with subsequent PG synthesis. Molecular identity, 
localization and quantitative levels of molecular constituents of this pathway are described. 
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Material and Methods 
Vas Deferens Tissue Acquisition and Epithelial Cell Isolation. Porcine vas deferens were 55 
surgically excised immediately postmortem from sexually mature boars at a local swine 
production facility, placed in ice-cold Hank’s buffered salt solution (mM composition: 137 NaCl, 
5.4 KCl, 0.4 KH2PO4, 0.6 Na2HPO4, 5.5 glucose) and transported to the laboratory where 
isolation of porcine vas deferens epithelial cells for primary culture (1oPVD) was performed as 
described previously [20]. Distal human vas deferens (2 to 5 cm long) were obtained from a local 60 
hospital through procedures approved by both the University and hospital Institutional Review 
Boards. Isolation of human vas deferens epithelial cells for primary culture (1oHVD) has been 
described previously [21]. 
Cell Culture. 1oPVD, 1oHVD and PVD9902 (an immortalized epithelial cell line derived 
from porcine vas deferens [22]) were seeded on 25-cm2 tissue culture flasks or 24-well tissue 65 
culture plates and grown in Dubelcco’s Modified Eagle’s Medium (Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (Atlanta Biologicals, Atlanta, GA) and 1% penicillin 
and streptomycin (Invitrogen) with media changes every other day. Upon reaching confluency, 
cells were lifted with phosphate buffer saline (PBS) containing trypsin and 
ethylenediaminetetraacetic acid (Invitrogen), suspended, and seeded on 1.13 or 0.33 cm2 70 
Transwell permeable supports (Corning-Costar, Cambridge, MA) to form polarized epithelial 
cell monolayers. Cells were cultured with media changes every other day until assayed in 
modified Ussing chambers and/or used for other experimental protocols, typically 11-14 days. 
Electrophysiology. Epithelial cell monolayers were mounted in modified Ussing flux 
chambers (model  DCV9; Navicyte, San Diego, CA), bathed symmetrically in Ringer solution 75 
(composition in mM: 120 NaCl, 25 NaHCO3, 3.3 KH2PO4, 0.83 K2HPO4, 1.2 CaCl2, 1.2 MgCl2), 
maintained at 39oC for 1oPVD and PVD9902 or 37oC for 1oHVD and bubbled with 5% CO2-
95% O2 to provide mixing and pH stability. Monolayers were clamped to 0 mV and ISC was 
measured continuously with a voltage-clamp apparatus (model 558C; University of Iowa, Dept. 
of Bioengineering, Iowa City, IA). Data were acquired digitally at 1 Hz with an Intel-based 80 
computer using an MP100A-CE interface and AcqKnowledge software (version 3.7.3; BIOPAC 
Systems, Santa Barbara, CA). Once recordings began, this system automatically generated a 5 
mV bipolar pulse every 100 secs. The resulting change in ISC was used to calculate transepithelial 
electrical resistance (RTE) according to Ohm’s law. To test for various experimental hypotheses, 
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monolayers were exposed to different compounds: LBK, BK, des-Arg9-BK, HOE140 (Bachem, 85 
King of Prussia, PA); des-Arg10-HOE140 (Anaspec, San Jose, CA); PGE2, butaprost, 
indomethacin, amiloride, bumetanide (Sigma-Aldrich, Saint Louis, MO); 1-OH prostaglandin E1 
(1-OH PGE1) and sulprostone (Cayman Chemical, Ann Arbor, MI). 
Western Blot Analysis. 1oPVD monolayers cultured on permeable supports were lysed 
and solubilized in buffer containing protease inhibitors (Calbiochem, San Diego, CA). After 90 
centrifugation at 14000 rpm and 4oC for 15 min, the supernatant protein isolates were transferred 
to a fresh tube and quantified by a ND-1000 spectrophotometer (NanoDrop Technologies, 
Wilmington, DE). Protein sample aliquots were prepared for electrophoresis by addition of 
loading buffer (Boston Bioproducts, Worcester, MA), ß-mercaptoethanol (Sigma-Aldrich) and 
heated to 95oC for 5 min. Sodium dodecyl sulfate polyacrylamide gel electrophoresis was 95 
conducted with 4-20% polyacrylamide gradient pre-cast gels (Bio-rad Laboratories, Hercules, 
CA) at 150 V for approximately 1.5 h or until optimal separation of pre-stained protein standards 
(Bio-rad Laboratories) was obtained. Electro-transfer onto PVDF membranes (Millipore, 
Billerica, MA) was carried out in methanol-containing transfer buffer  (20% v/v) at 30V for 3 h. 
Blots were blocked by blotting grade non-fat dry milk (Bio-rad Laboratories, 5% w/v) and 100 
exposed to 0.08 μg/ml of anti-BDKRB2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 
or anti-BDKRB2 antibody pre-adsorbed by its immunizing peptide. A suitable horseradish 
peroxidase (HRP) conjugated secondary antibody was employed to develop chemiluminescence 
signals that were imaged by a FluorChem HD2 (Alpha Innotech Corporation, San Leandro, CA). 
Immunocytochemistry. Segments (~1 cm) of both proximal and distal porcine vas 105 
deferens were snap-frozen in liquid N2 immediately after ducts were obtained and were 
transported to the laboratory where they were kept frozen while being embedded in tissue 
freezing medium (Richard-Allan Scientific, Kalamazoo, MI) for cryosectioning. Sections (18 
μm) were collected onto poly-L-lysine-coated slides, fixed in 4% paraformaldehyde in PBS for 1 
hour, PBS-washed five times and subjected to conventional immunocytochemistry labeling. In 110 
short, tissues were blocked with bovine serum albumin (Sigma-Aldrich) in PBS and exposed to 2 
μg/ml of anti-BDKRB2 antibody, anti-BDKRB2 antibody pre-adsorbed by its immunizing 
peptide, or vehicle only, overnight, in a humidified chamber. Tissues were PBS-washed five 
times and subsequently exposed to a suitable fluorophore-conjugated secondary antibody (Alexa 
Fluor 488, Invitrogen) and to a fluorescent chromatin dye (TO-PRO-3, Invitrogen) for 1 hour. 115 
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Following 5 PBS-washes, cover slips were mounted with Fluoromount-G (SouthernBiotech, 
Birmingham, AL) and confocal microscopy was performed (LSM 510 META; Carl Zeiss 
Microimaging Inc, Thornwood, NY). 
RNA Isolation and Semi-Quantitative RT-PCR. Total RNA was isolated from epithelial 
cell monolayers following Ussing chamber protocols, using an RNeasy Mini Kit (Qiagen, 120 
Valencia, CA) according to the manufacturer’s recommendations. RNA quality was assessed 
with a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA concentration within 
isolates was determined using a ND-1000 spectrophotometer and all samples were diluted to 100 
ng/μl. One-step RT-PCR was performed using a One-step RT-PCR kit (Qiagen) according to 
manufacturer’s recommendations, with 100 ng of RNA per reaction. Single-target reactions were 125 
conducted using primer sets designed upon previously published cDNA sequences when 
available. Porcine PTGER1, PTGER2 and PTGER4 coding sequences had not been published. 
Thus, sequence homology searches were performed by querying the porcine gene index from 
The Institute for Genomic Research (TIGR) with the respective human sequences. Such searches 
yielded at least one hit with relevant homology to the PTGER2 and PTGER4 cDNAs and these 130 
candidate sequences were used in the design of primer sets. No porcine candidate-sequences 
were identified for the PTGER1 and the human PTGER1 sequence was used to design a primer 
set for the porcine target. Primer sequences, annealing temperatures, expected amplicon length 
and sequence accession numbers are presented in Table 1. SYBR Green I (Molecular Probes, 
Eugene, OR) fluorescence signals emitted at each amplification cycle were detected and 135 
quantified by a SmartCycler (Cepheid, Sunnyvale, CA). Transcript abundance measurements in 
any given RNA sample were performed by reactions carried out in duplicates. Melting analysis 
was performed at the end of every amplification phase and reaction products were subjected to 
agarose gel electrophoresis, sequencing and computer-based identity analysis. Acquired 
threshold cycle (Ct) values for target genes were normalized to the reference porcine gene 140 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) according to the amplification efficiency 
method [23]. 
Complementary DNA Sequencing. RT-PCR products resolved on agarose gels were 
excised and purified with a QIAquick gel extraction kit (Qiagen) and the resulting cDNA 
templates were sequenced with a CEQ8000 (Beckman Coulter, Fullerton, CA) according to 145 
manufacturer’s recommendations. 
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Statistical Analysis. Paired and unpaired t-tests and analysis of variance (ANOVA) were 
performed as appropriate. These tests and the calculation of means and standard error of the 
mean (SEM) were performed with Microsoft Office Excel 2003 (version 11.8211.8202; 
Microsoft Corporation, Redmond, WA). A modified Michaelis-Menten (M-M) equation: y = 150 
[ax]/[c + x], where y is the measured ΔISC, a is the maximum ΔISC (ΔISC -MAX), x is the 
concentration of agonist and c is the concentration required for a half-maximal response (i.e., the 
apparent KD or kapp) was fitted to data collected from concentration-dependency experiments. All 
graphs and curve fittings were made with SigmaPlot (version 6.0; Systat Software Inc., Point 
Richmond, CA). 155 
 
Results 
Bradykinins Induce Anion Secretion Across Vas Deferens Epithelia 
To investigate whether BKs modulate ion transport across vas deferens epithelia, cells 
derived from human and porcine vas deferens, as well as the vas deferens epithelial cell line 160 
PVD9902 were used. 1oPVD monolayers (n = 7 animals) revealed basal ISC and RTE of 0.7 ± 0.2 
μA*cm-2 and 4400 ± 610 Ω*cm2, respectively. LBK (500 nM), symmetrically added to the 
bathing media, caused a rapid bimodal increase in ISC that formed a first peak before it decreased 
briefly and generated a second peak (Fig. 1A). ΔISC-MAX was 5.1 ± 1.0 μA*cm-2. ISC then receded 
to a nadir and rose again to a plateau that lasted several minutes. Sustained ISC was partially 165 
sensitive to basolateral bumetanide (20 μM; data not shown) indicating that a portion of the ISC is 
attributable to Cl- secretion, as has been shown for other agonists affecting vas deferens 
epithelial cells [20, 24]. RTE rapidly but transiently declined upon exposure to LBK. The lowest 
value was consistently observed at the first voltage pulse following LBK exposure and then RTE 
recovered towards pretreatment values. This is depicted in the deflections that are of maximal 170 
magnitude at the onset of responses and their subsequent and progressive narrowing. Maximal 
decrease in RTE (ΔRTE-MAX) was 3160 ± 500 Ω*cm2. Experiments carried out with 1 nM LBK, the 
lowest concentration tested, revealed ΔISC-MAX of 4.5 ± 1.2 μA*cm-2 (n = 5 animals), which was 
not different from the results obtained with 500 nM. However, ISC tracings produced by 1 nM 
formed a single transient peak that relaxed to basal levels and then rose to a plateau (Fig. 1B). To 175 
assess whether LBK produced a sustained effect, ΔISC measured between 900 and 1000 secs after 
the onset of responses were determined: ΔISC  was 1.1 ± 0.1 μA*cm-2 and 0.9 ± 0.3 μA*cm-2 for 
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responses acquired with 500 nM and 1 nM LBK, respectively. At 1 nM, ΔRTE-MAX was 2170 ± 
670 Ω*cm2 and, similar to that observed with 500 nM, RTE was reduced to the lowest value with 
the onset of each response and then recovered gradually towards pretreatment values. Still in the 180 
context of the first experiments, PVD9902 monolayers (n = 6) were assessed with 500 nM LBK. 
From basal ISC and RTE at 0.4 ± 0.1 μA*cm-2 and 6900 ± 1400 Ω*cm2, respectively, these 
monolayers responded with ΔISC-MAX of 5.6 ± 1.0 μA*cm-2 and ΔRTE-MAX of 2720 ± 650 Ω*cm2 
(Fig. 1C). ISC tracings from PVD9902 revealed a sharp and rapid rise in ISC to form a single peak 
that declines toward baseline in about 300 s. The magnitude of responses acquired from 1oPVD 185 
and PVD9902 at the tested concentrations were indistinguishable (P < 0.05). Subsequent 
experiments tested for bradykinin modulation of ion transport across 1oHVD monolayers. A first 
1oHVD monolayer was tested with 1 nM LBK, which produced a small ΔISC-MAX (~0.8 μA*cm-2). 
After 400 s, a second and cumulative LBK addition brought the concentration to 10 nM and the 
recorded ΔISC-MAX was 6.4 μA*cm-2 for this monolayer. Based on this single observation all 190 
subsequent experiments with 1oHVD were conducted with 10 nM LBK. 1oHVD epithelial 
monolayers (n = 6 individuals) were, at first, exposed to 10 μM amiloride, to which they 
consistently responded with decrease in ISC (data not shown, [21]). These monolayers were then 
allowed sufficient time to establish a new baseline, at which point they exhibited basal ISC of 3.9 
± 1.2 μA*cm-2 and basal RTE of 550 ± 180 Ω*cm2. Upon LBK exposure (10 nM), 1oHVD 195 
monolayers responded with a rapid increase in ISC that formed one single peak (Fig. 1D), in a 
pattern similar to 1oPVD responses acquired following exposure to 1 nM LBK. 1oHVD 
responses produced ΔISC-MAX of 9.4 ± 2.2 μA*cm-2 and ΔRTE-MAX of 205 ± 75 Ω*cm2. Taken 
together, the results presented in Fig. 1 demonstrate similar ion transport responses to LBK for 
vas deferens epithelial cells from 3 sources, an immortalized cell line and primary cultures of 200 
cells isolated from both porcine and human tissues. 
Bradykinin-Induced Ion Transport across Vas Deferens Epithelia is Stimulated by Activation of 
BDKRB2 
A subset of four assays was performed to determine which BK receptor subtype is 
present in and linked to ion transport across vas deferens epithelia by exposing paired 1oPVD 205 
monolayers to selective agonists and/or antagonists of bradykinin 1 receptor subtype (BDKRB1) 
and BDKRB2. Each assay employed cells derived from one boar that gave rise to six 
monolayers. LBK and BK are BDKRB2-selective agonists whereas des-Arg9-BK is a BDKRB1-
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selective agonist. Results presented in Fig. 2 demonstrate that BDKRB2, but not BDKRB1 
agonists stimulated ISC. Furthermore, concurrent exposure to a BDKRB2 antagonist, HOE140, 210 
precluded an effect of BK on paired monolayers. The BDKRB1-antagonist, des-Arg10-HOE140, 
despite being used at a super maximal concentration (5 μM), caused only a modest inhibition of 
the BK-induced change in ISC, which did not achieve statistical significance (n = 4). These results 
provide compelling evidence that BDKRB2s mediate the effect of BK and/or LBK on ISC across 
vas deferens epithelial cells. 215 
BDKRB2 Immunoreactivity is Present in Both Cultured Vas Deferens Epithelial Cells and in 
Vivo 
Western blot analysis targeted expression of BDKRB2 in protein samples isolated from 
1oPVD monolayers. Outcomes reveal a most prominent signal with mobility consistent to the 
theoretical molecular weight (41 kDa), calculated for the human BDKRB2 (Fig. 3A). Four other 220 
bands of reduced intensity were present. All bands had reduced intensity in the lane that had less 
protein loaded. The identity of these bands is unknown although all signals were absent when the 
primary antibody was pre-adsorbed by the immunizing peptide regardless of the amount of 
protein loaded (Fig. 3B).  
Immunocytochemistry and confocal microscopy analysis were carried out to investigate 225 
expression and localization of BDKRB2s in transverse sections of freshly excised porcine vas 
deferens. BDKRB2-immunoreactitivy was localized to cells lining the duct. Receptor 
immunoreactivity was present throughout the epithelium while non-epithelial cells were devoid 
of labeling (Fig. 3C and E). BDKRB2-immunoreactitivy was present in the same labeling pattern 
on sections of both proximal and distal vas deferens epithelia (not shown). Tissue sections made 230 
in a serial manner and exposed to pre-adsorbed primary antibody exhibited only very modest 
labeling (Fig. 3D), and sections probed with the secondary antibody only exhibited no labeling 
(not shown). BDKRB2-immunoreactitivy was also present at the endothelium of capillaries 
present in the vicinity of the epithelium and at the endothelium of veins located outside the vas 
deferens muscular layer (not shown). 235 
Messenger RNA Coding for BDKRB2 But Not BDKRB1 is Present in Cultured Vas Deferens 
Epithelial Cells 
Semi-quantitative RT-PCR analysis of RNA isolated from 1oPVD monolayers derived 
from 3 animals revealed that the BDKRB2 mRNA is expressed at a level equivalent to 16.45 ± 
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0.45 % of the total number of transcripts expressed from the housekeeping gene GAPDH (n = 6). 240 
The BDKRB1 transcript was detected only once in a series of eight reactions (two reactions per 
RNA sample; each sample isolated from monolayers derived from one of 4 animals). Ct values 
for the porcine BDKRB2 and porcine GAPDH mRNAs were 20.59 ± 0.24 and 17.90 ± 0.09, 
respectively. The BDKRB1 positive reaction had a Ct of 38.70, which shows that even when 
detected, BDKRB1 mRNA is >105 less abundant than the BDKRB2 mRNA. Sequencing of the 245 
amplicons derived from these reactions was performed and all products proved to be of expected 
identity. 
Bradykinins Effect on ISC and RTE across Cultured Vas Deferens Epithelial Cells is 
Indomethacin-Sensitive 
To determine whether the BDKRB2-induced ΔISC includes an increase in PTGS activity, 250 
monolayers were exposed to indomethacin or vehicle control for 10 to 15 minutes prior to LBK 
exposure. Indomethacin was without effect on ISC or RTE. Subsequent exposure to LBK (500 nM) 
caused a ΔISC-MAX and ΔRTE-MAX of 0.9 ± 0.5 μA*cm-2 and 1630 ± 390 Ω*cm2 respectively. These 
ΔISC responses in the presence of indomethacin are less than 20% when compared to vehicle-
treated controls (Fig. 4). The possibility remained that, although the ΔISC-MAX was reduced by 255 
indomethacin, net flux, measured as area under the ISC curve might not have changed. Thus, the 
magnitude of responses were also defined over the course of 300 s and revealed an indomethacin 
suppressive effect (Fig. 4C). Both ΔISC-MAX and the net change in flux over 300 s were affected to 
a similar extent by indomethacin. In addition, the effect of LBK on RTE was approximately 50% 
less in the presence of indomethacin (Fig. 4D). 260 
Monolayers derived from the PVD9902 cell line and subjected to the same protocol (n = 
6) displayed no effect of exposure to indomethacin (500 nM). Once exposed to LBK (500 nM), 
these monolayers responded with ΔISC-MAX and ΔRTE-MAX of 0.39 ± 0.06 μA*cm-2 and 440 ± 200 
Ω*cm2 respectively, which is less than 7% of the ΔISC-MAX and less than 17 % of the ΔRTE-MAX 
exhibited by paired monolayers not treated with indomethacin (Fig. 5). 265 
1oHVD cultures were assessed for an effect of LBK (10 nM) in the absence or presence 
of indomethacin (2 μM). Monolayers of 1oHVD were assessed twice for effects of LBK in the 
absence and presence of indomethacin: either first with LBK only, then replaced in culture for 3-
5 days and then evaluated a second time in the presence of indomethacin, or in the reverse order. 
Baseline values for indomethacin treated 1oHVD monolayers (n = 6 monolayers derived from 6 270 
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donors) were 2.4 ± 1.5 μA*cm-2 and 721 ± 382 Ω*cm2. Exposure to indomethacin produced no 
measurable changes in ISC or RTE. Responses to LBK within the indomethacin-treated group 
constituted ΔISC-MAX and ΔRTE-MAX of 3.7 ± 0.5 μA*cm-2 and 196 ± 108 Ω*cm2 respectively. This 
ΔISC-MAX is significantly less than the untreated group (Fig. 5C), but 1oHVD exhibited no 
difference in terms of ΔRTE-MAX (Fig. 5D). Taken together, these results support the inference 275 
that, in vas deferens epithelial cells, BK modulates ion transport via activation of 
cyclooxygenases that likely contribute to PG synthesis. 
PTGS2 mRNA is Highly Expressed in Cultured Porcine Vas Deferens Epithelia 
Indomethacin inhibits both PTGS1 and PTGS2. Thus, experiments were conducted to 
determine the relative expression of mRNA coding for the PTGS isoforms in 1oPVD cells. Semi-280 
quantitative RT-PCR was carried out with RNA isolated from monolayers derived from 5 
animals. Ct values were: 18.72 ± 0.60 for GAPDH; 21.25 ± 0.35 for PTGS2 and 25.68 ± 0.22 for 
PTGS1. Normalization of targeted PTGS mRNA to GAPDH reveals that the PTGS2 transcript 
abundance was more than 20 times greater than the PTGS1 transcript and as much as 20% of 
GAPDH (Fig. 6). Resulting amplicons had expected mobility on agarose gels and subsequent 285 
cDNA sequencing proved expected identity (data not shown). 
PTGER4 and PTGER2 Contribute to Anion Secretion across Vas Deferens Epithelia 
Changes in ISC exhibited by 1oPVD were recorded by a modified Ussing chamber as 
monolayers were exposed to cumulative concentrations of subtype selective prostaglandin E 
receptor agonists: sulprostone (PTGER1 and PTGER3), butaprost (PTGER2) and 1-OH PGE1 290 
(PTGER4). PGE2, the primary product of PTGS activity, although a non-selective PTGER 
agonist, was also used in this concentration response study. These assays were carried out in a 
paired manner so that cells from each animal had at least one monolayer exposed to each 
compound. Results are summarized in Fig. 7. Concentration-dependent stimulation of ISC was 
observed with PGE2, 1-OH PGE1 and butaprost, while sulprostone was without a remarkable 295 
effect, even at the greatest concentration tested. Effects at the highest concentration tested (1 
µM), were not different for PGE2, 1-OH PGE1 or butaprost. However, quantitative analysis of 
the concentration dependence revealed some differences. Responses to 1-OH PGE1 and 
butaprost were well-fitted by a modified M-M function with derived macroscopic dissociation 
constants (kapp) of 20.2 ± 6.5 nM and 37.7 ± 18.4 nM, respectively. Visual inspection revealed 300 
that concentration-dependent responses to PGE2 were not fitted well by the M-M function. 
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Nonetheless, at every concentration tested, the response to PGE2 was greater than the response 
to any of the receptor-selective agonists. Thus, the rank order of potency was PGE2 > 1-OH 
PGE1 > butaprost >>> sulprostone, suggesting that both PTGER4 and PTGER2 can contribute 
to the response. 305 
  Semi-quantitative RT-PCR revealed a direct correlation between the pharmacological 
data described above and transcript abundance for PTGER subtypes measured in RNA isolated 
from 1oPVD monolayers. A comprehensive read-out of PTGERs expression levels is 
summarized in Fig. 8. PTGER4 mRNA was approximately 4 times more abundant than PTGER2 
mRNA and more than 60 times more abundant than PTGER3 mRNA. Reactions for PTGER1 310 
failed to detect this transcript in 6 attempts. Single amplicons of expected mobility derived from 
reactions targeting PTGER2, PTGER3 and PTGER4 mRNAs were sequenced and revealed 
expected identity (data not shown). Thus, both pharmacological and molecular data support the 
conclusion that PGs acting at PTGER4 and PTGER2 contribute to ion transport that is stimulated 
by LBK. 315 
 
Discussion 
 Results presented here demonstrate for the first time that BKs with preferential affinity to 
the BDKRB2 elicit an increase in ISC that is indicative of anion secretion by cells lining the vas 
deferens. Molecular and functional data derived from both porcine and human epithelial cell 320 
models are reported that describe a role for BK and the BDKRB2 in vas deferens epithelial 
physiology. 1oPVD cells respond to BK in a HOE140-sensitive manner and, likewise, PVD9902 
respond to BKs. Native porcine vas deferens tissues exhibit epithelial BDKRB2-
immunoreactivity. LBK also induces a ΔISC that is indicative of anion secretion in 1oHVD. Data 
derived from these 3 epithelial models, along with BDKRB2-immunoreactivity in native tissue, 325 
support the inference that activation of BDKRB2 upregulates PTGS activity, mostly PTGS2, to 
synthesize PGs that ultimately bind to PTGER4 and/or PTGER2 to initiate pathways leading to 
anion secretion across the vas deferens epithelium. It is expected that such cellular events change 
the vas deferens luminal fluid: its volume, ion composition and pH. 
The rapid BK-induced increase in ISC was accompanied by a similarly rapid and drastic 330 
reduction in RTE, which is suggestive of the opening of ion channels, likely CFTR. Functional 
hallmarks of this ion channel have been reported previously for these cell-based systems [20-22, 
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25]. Such observations are in keeping with the bradykinin effects observed in epithelia elsewhere 
in the male reproductive tract, most notably in epididymal epithelia [15-17, 26]. Epithelial 
systems where the qualitative aspect of BK-induced anion secretion have been at least partially 335 
elucidated, as in the kidney [5-8] and colon [10, 11], provide further support for the proposed 
link between BDKRB2 activation and an anion secretory effector such as CFTR in vas deferens 
epithelia. Both porcine and human vas deferens epithelial cells respond to submicromolar 
concentrations of BK with substantial anion secretion, although the concentrations employed are 
approximately 10 to 100 times greater than the circulating plasma levels of BK [27]. Within this 340 
context, it should be noted that epithelia lining the male reproductive tract, specifically 
epididymal epithelia, have been shown to express tK immunoreactivity [12], which suggests that 
BK synthesis can occur at the apical membrane of epithelium lining other portions of the male 
excurrent duct. 
Results suggest that the BDKRB2 is solely responsible for the ion transport observed 345 
upon BK exposure. Stimulation was fully blocked by the BDKRB2 antagonist HOE140. 
Furthermore, BK, which is a BDKRB2 selective agonist, stimulated ISC whereas the BDKRB1 
selective agonist des-Arg9-BK caused no appreciable change in ISC. The BDKRB1 antagonist 
des-Arg10-HOE140 was associated with a reduction in BK-stimulated ISC, although this 
difference did not achieve statistical significance. This observation is consistent with reports that 350 
BDKRB1 antagonists developed from the des-Arg-fragment of HOE140 exert potent 
antagonistic effect on the BDKRB1 while exhibiting weak antagonistic effects on the BDKRB2 
[2]. 
 The 1oPVD system expresses the BDKRB2 at the protein level as indicated by Western 
blot analysis. The porcine coding sequence is not fully cloned to date but the theoretical mobility 355 
of the human BDKRB2 is 41 kDa. In these assays, the most prominent band had mobility 
between the protein standards 37 and 50 kDa. In addition, other signals of lesser intensity were 
present. Two different signals were present at and below the 37 kDa marker and two other 
signals were present below and above the 50 kDa marker. While it becomes difficult to account 
for the origin of these signals, it should be noted that a signal with mobility greater than the 360 
theoretical value has been reported for the human BDKRB2 [28] and that all signals were 
substantially reduced or eliminated by pre-adsorption of anti-BDKRB2 with the immunizing 
peptide. BDKRB2 immunoreactivity was observed in the majority of cells composing the intact 
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porcine vas deferens epithelium. Principal, basal, clear, narrow and dark (pencil) cells are 
reported as cell types within this epithelium although principal cells account for the vast majority 365 
of the cells that line the duct [29, 30]. Micrographs obtained following BDKRB2 
immunolabeling indicated that this receptor is present throughout most cells composing the vas 
deferens epithelium. The labeling pattern allows, with a reasonable degree of certainty, for the 
inference that principal cells express the BDKRB2 in vivo. At the transcriptional level, BDKRB2 
is highly expressed in 1oPVD monolayers, which seems to place this cell model apart from others 370 
in this regard. G-protein coupled receptors - BDKRB2 included – are generally expressed at low 
levels in mammalian cells despite their wide participation in cellular signal transduction in 
several tissues. This has made necessary the development of cellular expression systems, largely 
based on insect cells, in order to obtain reasonable yields of BDKRB2 for various applications 
[31-33]. The BDKRB1 transcript is, however, virtually absent from the transcriptome of 1oPVD 375 
monolayers. As described in the results, this transcript was amplified only once out of 8 attempts 
using 1oPVD RNA and that amplification generated a 38.7 Ct value, which indicated at least 
100,000-fold fewer copies than BDKRB2 mRNA. These data provide further support for an 
anion secretion pathway that is stimulated by the BDKRB2 and not the BDKRB1 in vas deferens 
epithelia. The BDKRB2 is present in several tissues and is constitutively expressed under 380 
physiological conditions, while the BDKRB1 is an inducible form of the bradykinin receptor that 
is expressed in the context of inflammation and/or trauma [2, 34]. The possibility for BDKRB1 
modulation, however, does remain. BDKRB1 was transcribed, translated, and expressed at the 
basolateral membrane of colonic epithelia within 3 hours after being mounted in Ussing 
chambers [35]. The 1oPVD monolayer from which that RT-PCR amplification of BDKRB1 385 
mRNA was derived remained in the Ussing chamber for approximately 45 minutes. That single 
observation where the BDKRB1 transcript was amplified could reflect rapid induction, although 
this possibility remains to be tested. 
Exposure to the non-selective PTGS inhibitor indomethacin significantly reduced LBK 
responses in all three vas deferens epithelial cell models tested. This observation leads to the 390 
conclusion that, similar to what has been demonstrated in epididymal epithelia [15-17], BKs 
activate PTGS and upregulate PG synthesis in vas deferens epithelia. PGs, in turn, bind PTGERs 
to initiate a pathway (or pathways) leading to anion secretion. In 1oPVD, PTGS2 expression is 
nearly 20 times greater than PTGS1 expression. This observation is consistent with a previous 
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report that defined relative levels of these transcripts in murine vas deferens [18]. PTGSs, and 395 
most prominently PTGS2, have been subject of substantial pharmaceutical development. 
Recently, selective inhibitors of PTGS2 (rofecoxib, celecoxib, valdecoxib) have been actively 
marketed as non-steroidal anti-inflammatory drugs although rofecoxib was withdrawn. Since 
then, attention has turned to side-effects occurring in the kidney [36] where PTGS2 is 
constitutively expressed. The high levels of PTGS2 expression in the vas deferens as well as its 400 
role in modulating ion transport make it reasonable to believe that therapeutic use of these 
compounds may impact fertility at the level of epithelia lining the male excurrent duct. 
Concentration-dependent responses to PGs are exhibited by 1oPVD epithelial cell 
monolayers. The outcomes suggest that the PTGER4 and/or PTGER2 account for the response to 
PGE2 in the vas deferens. Butaprost is the most selective PTGER2 agonist available among 405 
synthetic prostaglandins and possesses a reported kapp of 110 nM, while 1-OH PGE1 has 
PTGER4 selectivity with a reported kapp of 190 nM [37]. 1oPVD responded to both of these 
selective agonists at concentrations at or slightly below their reported kapp. PGE2 is a powerful 
non-selective agonist of all PTGER subtypes and its concentration-dependent changes in ISC 
were not fitted well by the M-M function. This is consistent with the notion that two PTGER 410 
subtypes can modulate ISC across vas deferens epithelia. Nonetheless, butaprost, 1-OH PGE1 and 
PGE2 produced virtually the same ΔISC at the greatest concentration tested, which suggests the 
existence of a response limiting factor, most likely the ion transporting proteins carrying out their 
function at a maximal rate when the greatest agonist concentration was effectively in the system. 
Both PTGER4 and PTGER2 are GS-protein coupled receptors, suggesting substantial adenylyl 415 
cyclase activation. Previously reported data from this laboratory demonstrated cAMP synthesis 
in 1oPVD upon exposure to agonists other than PG [38]. PTGER2 and PTGER4 reportedly 
modulate ion transport induced by PGE2 elsewhere in the male reproductive tract, specifically in 
epididymal epithelia [15]. The relative abundances of mRNA for prostaglandin E receptor 
subtypes described here for vas deferens epithelia seems to set the male excurrent duct apart 420 
from other urogenital epithelia. Gene expression analysis performed on 2 mice strains reveals 
that all EP receptor transcripts are expressed in the kidney of both strains but that PTGER4 
mRNA is least abundant while PTGER1 mRNA is the most abundant [39]. In the second mouse 
strain, kidney levels of PTGER4 expression are comparable to that of PTGER1 and PTGER3, 
and well below the levels of medullary PTGER2 mRNA. Further evidence is available that 425 
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supports high expression of the PTGER1 and PTGER3 transcripts in the kidney but modest 
expression of the PTGER4 and PTGER2 transcripts [40]. These PTGER expression profiles 
place the kidney as an organ system where the expected effect of PGE2 is via inositol 
thriphosphate and reduction in cellular cAMP levels, as opposed to signaling through 
phosphatidylinositol 3 (PI3)-kinase and increase in cAMP levels that, based upon our 430 
observations, is expected in the vas deferens. 
PGs modulate acid and base transport. In the duodenum, PGs are required for the 
modulation of net bicarbonate secretion and cause alkalinization of the duodenal lumen. In this 
segment of the gastrointestinal tract, bicarbonate secretion is upregulated through activation of 
PTGER3 and PTGER4 [41-43]; cAMP-, calcium- and PI3-kinase-dependent pathways [44]; and 435 
by modulating activity of apically expressed bicarbonate exchangers such as SLC26A6 [45]. 
Although further investigation is needed to elucidate the qualitative aspects of anion secretion 
induced by BKs and PGs in vas deferens epithelium, this laboratory demonstrated that anion 
secretion in this tissue is bicarbonate-dependent [24]. Using a variety of ion substitution 
conditions and selective permeabilization of either the apical or basolateral membranes of 440 
1oPVDs, bicarbonate was necessary for the maintenance of sustained changes in ISC upon 
forskolin stimulation and required for changes in ISC to occur at the isolated basolateral 
membrane. Additionally, mRNA coding for a collection of bicarbonate co-transporters and 
exchangers is expressed in porcine vas deferens epithelia, including SLC4A4, SLC26A3, 
SLC26A4 and SLC26A6 [22, 24]. Sperm bicarbonate uptake, while still in the male reproductive 445 
tract, is required for adequate sperm capacitation and the development of fertilizing capacity 
[46]. Taken together, these data make it reasonable to conclude that the vas deferens epithelium 
might be a substantial, if not the main, cellular contributor of bicarbonate secretion onto the 
environment to which sperm is exposed. 
 In conclusion, BKs act on the BDKRB2 to upregulate PTGS activity and the synthesis of 450 
PGs that then act on PTGER4 and/or PTGER2 to ultimately induce anion secretion across vas 
deferens epithelia. Anion secretion most likely modifies the male duct luminal environment to 
which sperm are exposed and thus may modulate sperm function and ultimately, male fertility. 
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Figure Legends 
 
Figure 1. Lysylbradykinin (LBK) induces anion secretion across vas deferens epithelial 595 
monolayers. A. When exposed to 500 nM, porcine vas deferens epithelial cell monolayers 
derived from primary cultures (1oPVD) exhibit two short term peaks of short circuit current (ISC) 
before a later and sustained rise in ISC takes place. B. 1oPVD monolayers respond to 1 nM LBK 
and consistently exhibit one single peak and a late rise in ISC. PVD9902 cell monolayers (C) and 
primary cultures of human vas deferens epithelial cells (D) also respond to LBK with a transient 600 
increase in ISC. Results presented are typical of 5-7 observations for each condition. 
 
Figure 2. Bradykinin 2 receptor subtype (BDKRB2) mediates bradykinin-induced ion transport 
across 1oPVD. A selective BDKRB2 agonist (bradykinin, BK) elicits responses that are absent 
when paired monolayers are pre-treated with the selective BDKRB2 antagonist HOE140 but not 605 
when exposed to des-Arg10-HOE140, a potent bradykinin 1 receptor subtype (BDKRB1) 
antagonist with weak antagonist effect at BDKRB2. Paired monolayers exposed to the selective 
BDKRB1 agonist des-Arg9-BK failed to exhibit changes in ISC (n = 4). * indicates significant 
difference from paired monolayers exposed to BK only (P < 0.05). 
 610 
Figure 3. BDKRB2-immunoreactivity is present in 1oPVD and native porcine vas deferens 
epithelia. A. Chemiluminescence signals derived from an immunoblot probed with anti-
BDKRB2. The most prominent band (arrow) reveals mobility that is consistent to the theoretical 
mobility calculated for human BDKRB2 (41 kDa). Signal strength is proportional to the amount 
 21
of protein loaded (20 and 10 µg in the left and right lane, respectively). B. No signal is observed 615 
when primary antibody is pre-adsorbed with immunizing peptide. Data are paired to panel A. C-
F. Transverse sections of native vas deferens exposed to anti-BDKRB2 antibody exhibit labeling 
(green) localized to most cells composing the epithelium (C and E). Image F reveals the 
corresponding bright field and nuclear staining (blue) to image E. Sections probed with pre-
adsorbed primary antibody showed little immunolabeling (D). Scale bar is representative of 50 620 
μm in C and D and 20 μm in E and F. Results are representative of several observations with 
tissues derived from 3 animals. 
 
Figure 4. Indomethacin inhibits the effect of LBK on 1oPVD ion transport. A. Typical responses 
for paired monolayers exposed to LBK in the absence (left) and presence (right) of 625 
indomethacin. Summarized results (n = 7) show that LBK-induced maximal change in ISC (B), 
average change in ISC for 300 s (C) and change in RTE (D) are 50-80% less in monolayers 
concurrently exposed to indomethacin. * indicates significant difference from vehicle treated 
control (P < 0.05). 
 630 
Figure 5. Indomethacin inhibits the effect of LBK in the PVD9902 cell line and primary human 
epithelial cell monolayers (1oHVD). PVD9902 exhibit pronounced change in ISC and RTE upon 
exposure to LBK (500 nM) that is largely precluded by indomethacin (500 nM) as indicated in 
panels A and B respectively (n = 6 each). 1oHVD ISC-responses to LBK (10 nM) are also 
sensitive to indomethacin (2 μM) (C), while changes in RTE are not affected (D) (n = 6 each). * 635 
indicates significant difference from vehicle treated control (P < 0.05). 
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Figure 6. PTGS2 mRNA abundance far exceeds that of PTGS1 in 1oPVD. Results expressed 
relative to GAPDH mRNA. Primer sequences and protocol parameters are presented in Table 1. 
(n = 10 reactions for each target, RNA derived from 5 animals). 640 
 
Figure 7. PTGER4 and PTGER2 mediate prostaglandin (PG) induced ion transport across 
1oPVD. Concentration response curves derived from cumulative concentrations of PTGER 
agonists applied to monolayers assayed in modified Ussing chambers are presented. Selective 
agonists of the PTGER4 and PTGER2 (1-OH PGE1 and butaprost, respectively) stimulate ISC as 645 
does PGE2, a non-selective agonist. Sulprostone, an agonist of PTGER1 and PTGER3, failed to 
cause changes in ISC. Sigmoidal curves represent the best fit of a modified Michaelis-Menten 
function to each data set. Parameters of the fits are reported in the text. Each point represents 10-
12 observations. 
 650 
Figure 8. PTGER4 mRNA abundance is approximately 4 times greater than that of PTGER2 and 
approximately 60 times greater than that of PTGER3 in 1oPVD. Results are expressed relative to 
GAPDH mRNA. Primer sequences and protocol parameters are presented in Table 1. (n = 6 
reactions for each target, RNA derived from 3 animals). 
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Tables 
 
 
 
Targeted 
Transcript Sense Primer Anti-Sense Primer 
Annealing 
Temp. (oC) 
Expected 
Product 
Length (bp) 
NCBI 
Accession 
BDKRB1 GTCTGAACGCGGCGGAAATCTACC ACTTGGACGGAGCGCAGCAGGAAC 64.3 340 AB051422 
BDKRB2 CAACGTCACCGCCTGCATCATCAA AAGGGCAGCCAGCAGACGACGAAC 61.9 240 AB051422 
PTGS1 TTTGCCCAACACTTCACCCACCAG AGCCCAGGAAGCAGCCCAAACA 60.8 293 AF207823 
PTGS2 CTGGCTGCGGGAACATAATAGAG TGGAAGGCGTCAGGCAGAAG 56.3 276 AF207824 
PTGER1 GGTGGGCCAGCTTGTCGGTATCAT CTCCCAGGCGCTCGGTGTTAGG 64.1 277 NM000955 
PTGER2 GGCGCGTGTGCACCTACTTTG AGGCGAGCACTGCGATGATGAG 60.8 324 EU241329 
PTGER3 TGGGGCCGGATCACGACTG CACGGGCTTCTCCTGGCTCTGT 58.6 349 U27083 
PTGER4 AGTCCCCTTTCCCAATGA GGCCGATCTCCCCACTAT 52.7 304 EU241330 
GAPDH CCAGCAAGAGCACGCGAGGAGGAG CGGGGGTCTGGGATGGAAACTGGA 61.2 117 X94251 
 
 
Table 1: Information associated with the performed gene expression analysis. 
Bradykinin-stimulated cyclooxygenase activity stimulates vas deferens epithelial anion secretion in vitro 
^TOP^ 
 
